Molecular Imaging And Biology

Journal Title：Molecular Imaging And Biology

Molecular Imaging and Biology (MIB) invites original contributions (research articles, review articles, commentaries, etc.) on the utilization of molecular imaging (i.e., nuclear imaging, optical imaging, autoradiography and pathology, MRI, MPI, ultrasound imaging, radiomics/genomics etc.) to investigate questions related to biology and health. The objective of MIB is to provide a forum to the discovery of molecular mechanisms of disease through the use of imaging techniques. We aim to investigate the biological nature of disease in patients and establish new molecular imaging diagnostic and therapy procedures.

Some areas that are covered are:

Preclinical and clinical imaging of macromolecular targets (e.g., genes, receptors, enzymes) involved in significant biological processes.

The design, characterization, and study of new molecular imaging probes and contrast agents for the functional interrogation of macromolecular targets.

Development and evaluation of imaging systems including instrumentation, image reconstruction algorithms, image analysis, and display.

Development of molecular assay approaches leading to quantification of the biological information obtained in molecular imaging.

Study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics.

Extension of in vitro and in vivo discoveries using disease models, into well designed clinical research investigations.

Clinical molecular imaging involving clinical investigations, clinical trials and medical management or cost-effectiveness studies.

分子成像与生物学 (MIB) 诚邀原创投稿（研究文章、评论文章、评论等），探讨如何利用分子成像（即核成像、光学成像、放射自显影和病理学、MRI、MPI、超声成像、放射组学/基因组学等）研究生物学和健康相关问题。MIB 的目标是提供一个论坛，通过利用成像技术来发现疾病的分子机制。我们的目标是研究患者疾病的生物学性质，并建立新的分子成像诊断和治疗程序。

涵盖的一些领域包括：

涉及重要生物过程的大分子靶标（例如基因、受体、酶）的临床前和临床成像。

设计、表征和研究用于功能性询问大分子靶标的新型分子成像探针和造影剂。

开发和评估成像系统，包括仪器、图像重建算法、图像分析和显示。

开发分子检测方法，以量化分子成像中获得的生物信息。

研究体内疾病动物模型，以开发新的分子诊断和治疗方法。

将使用疾病模型的体外和体内发现扩展到精心设计的临床研究调查中。

涉及临床研究、临床试验和医疗管理的临床分子成像或成本效益研究。

Molecular Imaging And Biology创刊于2005年，由Springer International Publishing出版商出版，收稿方向涵盖医学 - 核医学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 约3.0个月 ，影响因子指数3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。